UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000028300
Receipt No. R000032396
Scientific Title Impact of esophageal barrier function on proton pump inhibitor-resistant non erosive reflux disease (PPI-resistant NERD): discovering of pathophysiology and establishment of new therapeutic strategy
Date of disclosure of the study information 2017/07/25
Last modified on 2017/08/15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of esophageal barrier function on proton pump inhibitor-resistant non erosive reflux disease (PPI-resistant NERD): discovering of pathophysiology and establishment of new therapeutic strategy
Acronym Impaired esophageal barrier function causes PPI-resistant NERD.
Scientific Title Impact of esophageal barrier function on proton pump inhibitor-resistant non erosive reflux disease (PPI-resistant NERD): discovering of pathophysiology and establishment of new therapeutic strategy
Scientific Title:Acronym Impaired esophageal barrier function causes PPI-resistant NERD.
Region
Japan

Condition
Condition Proton pump inhibitor-resistant non erosive reflux disease (PPI-resistant NERD)
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the pathophysiology of proton pump inhibitor-resistant non erosive reflux
disease by measuring of esophageal barrier function in the biospy specimen of the patients and comparing to that of healthy volunteers
Basic objectives2 Others
Basic objectives -Others pathophysiology
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes comparison of difference in upper and lower esophageal epithelium of esophageal barrier function by mini ussing chamber system among patients of PPI-resistant NERD, functional heart burn and healthy volunteer.
Key secondary outcomes 1. comparison of esophageal barrier function between patients with heart burn (PPI-resistant NERD and FH) and healthy volunteer.
2. comparison of esophageal tight junctional protein in the bisopy specimen among PPI-resistant NERD, FH and healthy volunteer.
3. validation of esophageal histopathological difference amaong PPI-resistant NERD, FH and healthy volunteer.
4. elucidating relationship with intraesophageal luminal pH and esophageal epithelial barrier function between PPI-resistant NERD and FH.
5. comparison of difference in esophageal reflux contents and epithelial barrier function between PPI-resistant NERD and FH

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria <patient>
1. NERD and FH patietnts who fail to achieve remission of symptoms by daily dose of 20 mg rabeprazole for 8 weeks
2. Performance status 0
3. From 20 to 85 year-old patients, male:female=1:1
4. Outpatients of Tohoku university hospital from August 2017 until December 2010
5. Informed consent was obtained.
<healthy volunteer>
1. Drug-free, no symptom
2. From 20 to 85 year-old patients, male:female=1:1
3. Informed consent was obtained.
Key exclusion criteria <Only healthy volunteer>
1. Acid suppression drugs such as histamine 2 antagonist or PPI, Nsaids, steroids or immune suppression drugs were not administered 1 month before measurement of esophageal barrier function.
<patients and volunteers>
2. scheduled or history of abdominal surgical operation
3. Patients who prohibited to underwent endoscopy
4. pregnancy
5. severe diseases
6. psychogenic diseases
7. Patients whom we decided inappropriate to join in this study.
Target sample size 40

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kiyotaka Asanuma
Organization Tohoku university graduate school of medicine
Division name gastrotenterology
Zip code
Address 1-1 Seiryo machi Aobaku Sendai Miyagi, 980-8574
TEL 022-717-7171
Email takaxeve2004rosso@yahoo.com

Public contact
Name of contact person
1st name
Middle name
Last name Kiyotaka Asanuma
Organization Tohoku university graduate school of medicine
Division name gastrotenterology
Zip code
Address 1-1 Seiryo machi Aobaku Sendai Miyagi, 980-8574
TEL 022-717-7171
Homepage URL http://www.rinri.med.tohoku.ac.jp/portal
Email takaxeve2004rosso@yahoo.com

Sponsor
Institute Tohoku university graduate school of medicine dept. gastroenterology
Institute
Department

Funding Source
Organization Tohoku university graduate school of medicine dept. gastroenterology
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学病院消化器内科

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 07 Month 07 Day
Date of IRB
Anticipated trial start date
2017 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information no special information

Management information
Registered date
2017 Year 07 Month 20 Day
Last modified on
2017 Year 08 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032396

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.